Trials / Completed
CompletedNCT00377715
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
Phase 2, Double-Blind, Placebo-Controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 183 (actual)
- Sponsor
- Medivation, Inc. · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate the safety and potential benefit of Dimebon as compared to placebo in patients with mild to moderate Alzheimer's Disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dimebon | |
| DRUG | Placebo |
Timeline
- Start date
- 2005-09-01
- Primary completion
- 2006-08-01
- First posted
- 2006-09-18
- Last updated
- 2015-11-11
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT00377715. Inclusion in this directory is not an endorsement.